We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temperature Control During Dialysis Treatment

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00438295
First Posted: February 22, 2007
Last Update Posted: September 15, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Regional Hospital Holstebro
February 20, 2007
February 22, 2007
September 15, 2015
August 2006
Not Provided
Effect of temperature control on blood pressure, pulse rate and blod glucose during dialysis treatment
Same as current
Complete list of historical versions of study NCT00438295 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Temperature Control During Dialysis Treatment
Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure
The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control
To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Renal Failure, Chronic
Procedure: temperature control
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
18
May 2007
Not Provided

Inclusion Criteria:

  1. Age > 18 years,
  2. both men and women,
  3. chronic renal failure and dialysis treatment for at least three months

Exclusion Criteria:

  1. Heart failure,
  2. Lung insufficiency,
  3. Chronic liver disease,
  4. Diabetes mellitus,
  5. Malignant disease,
  6. Nephrotic syndrome,
  7. Lack of compliance,
  8. Unwillingness til participate
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00438295
MED.RES.2007.03.EBP
No
Not Provided
Not Provided
Not Provided
Regional Hospital Holstebro
Not Provided
Study Chair: Erling B Pedersen, Professor Regional Hospital Holstebro
Regional Hospital Holstebro
September 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP